<body><div id="content_start"></div> <article class="j-blog"><div class="n j-blog-meta j-blog-post--header"> <div class="j-text j-module n"> <span class="j-text j-blog-post--date"> 17. May 2015 </span> </div> <h1 class="j-blog-header j-blog-headline j-blog-post--headline">FORMULATION AND EVALUATION OF A 2-COMPONENT COMPOSITE EXCIPIENT"MICROCRYSTARLAC" AS A FILLER-BINDERFOR DIRECT COMPRESSION</h1></div><div class="post j-blog-content"> <div id="cc-matrix-2648383998"><div id="cc-m-9989877898" class="j-module n j-downloadDocument "> <a class="j-m-dowload" href="https://www.pharmaexcipients.com/wp-content/uploads/attachments/10.1.1.434.6420.pdf?t=1431856864" onclick="_gaq.push(['a._trackPageview', 'https://www.pharmaexcipients.com/wp-content/uploads/attachments/10.1.1.434.6420.pdf']);"> <img src="https://www.pharmaexcipients.com/wp-content/uploads/2018/08/pdf.png" width="51" height="51" class="downloadImage" alt="Download"> </a> <div data-name="download-description" class="descriptionContainer"> <div class="cc-m-download-title">FORMULATION AND EVALUATION OF A 2- COMPONENT COMPOSITE EXCIPIENT "MICROCRYSTARLAC" AS A FILLER-BINDER FOR DIRECT COMPRESSION</div> <div class="cc-m-download-description">International Journal of Scientific & Technology Research Volume 1, Issue 3, April 2012 ISSN 2277-8616</div> <div class="cc-m-download-file"> <div class="cc-m-download-file-name">10.1.1.434.6420.pdf</div> <div class="cc-m-download-file-info"> <span class="cc-m-download-file-type">Adobe Acrobat Document</span> <span class="cc-m-download-file-size">637.7 KB</span> </div> <div class="cc-m-download-file-link"><a href="https://www.pharmaexcipients.com/wp-content/uploads/attachments/10.1.1.434.6420.pdf?t=1431856864" onclick="_gaq.push(['a._trackPageview', 'https://www.pharmaexcipients.com/wp-content/uploads/attachments/10.1.1.434.6420.pdf']);" class="cc-m-download-link">Download</a></div> </div> </div> </div><div id="cc-m-9989878698" class="j-module n j-sharebuttons "><div class="cc-sharebuttons-element cc-sharebuttons-size-32 cc-sharebuttons-style-colored cc-sharebuttons-design-round cc-sharebuttons-align-left"> <a class="cc-sharebuttons-googleplus" href="https://plus.google.com/share?url=https://www.pharma-excipients.ch/2015/05/17/formulation-and-evaluation-of-a-2-component-composite-excipient-microcrystarlac-as-a-filler-binder-for-direct-compression/" title="Google+" target="_blank" rel="noopener"></a><a class="cc-sharebuttons-mail" href="mailto:?subject=FORMULATION%20AND%20EVALUATION%20OF%20A%202-%0ACOMPONENT%20COMPOSITE%20EXCIPIENT%0A%22MICROCRYSTARLAC%22%20AS%20A%20FILLER-BINDER%0AFOR%20DIRECT%20COMPRESSION&body=https://www.pharma-excipients.ch/2015/05/17/formulation-and-evaluation-of-a-2-component-composite-excipient-microcrystarlac-as-a-filler-binder-for-direct-compression/" title="Email" target="" rel="noopener"></a><a class="cc-sharebuttons-linkedin" href="http://www.linkedin.com/shareArticle?mini=true&url=https://www.pharma-excipients.ch/2015/05/17/formulation-and-evaluation-of-a-2-component-composite-excipient-microcrystarlac-as-a-filler-binder-for-direct-compression/&title=FORMULATION%20AND%20EVALUATION%20OF%20A%202-%0ACOMPONENT%20COMPOSITE%20EXCIPIENT%0A%22MICROCRYSTARLAC%22%20AS%20A%20FILLER-BINDER%0AFOR%20DIRECT%20COMPRESSION" title="LinkedIn" target="_blank" rel="noopener"></a></div></div></div> </div><div class="n" id="flexsocialbuttons"><div class="cc-sharebuttons-element cc-sharebuttons-size-32 cc-sharebuttons-style-colored cc-sharebuttons-design-round cc-sharebuttons-align-left"> <a class="cc-sharebuttons-googleplus" href="https://plus.google.com/share?url=https://www.pharma-excipients.ch/2015/05/17/formulation-and-evaluation-of-a-2-component-composite-excipient-microcrystarlac-as-a-filler-binder-for-direct-compression/" title="Google+" target="_blank" rel="noopener"></a><a class="cc-sharebuttons-mail" href="mailto:?subject=FORMULATION%20AND%20EVALUATION%20OF%20A%202-%0ACOMPONENT%20COMPOSITE%20EXCIPIENT%0A%22MICROCRYSTARLAC%22%20AS%20A%20FILLER-BINDER%0AFOR%20DIRECT%20COMPRESSION&body=https://www.pharma-excipients.ch/2015/05/17/formulation-and-evaluation-of-a-2-component-composite-excipient-microcrystarlac-as-a-filler-binder-for-direct-compression/" title="Email" target="" rel="noopener"></a><a class="cc-sharebuttons-linkedin" href="http://www.linkedin.com/shareArticle?mini=true&url=https://www.pharma-excipients.ch/2015/05/17/formulation-and-evaluation-of-a-2-component-composite-excipient-microcrystarlac-as-a-filler-binder-for-direct-compression/&title=FORMULATION%20AND%20EVALUATION%20OF%20A%202-%0ACOMPONENT%20COMPOSITE%20EXCIPIENT%0A%22MICROCRYSTARLAC%22%20AS%20A%20FILLER-BINDER%0AFOR%20DIRECT%20COMPRESSION" title="LinkedIn" target="_blank" rel="noopener"></a><a class="cc-sharebuttons-tumblr" href="http://www.tumblr.com/share?v=3&u=https://www.pharma-excipients.ch/2015/05/17/formulation-and-evaluation-of-a-2-component-composite-excipient-microcrystarlac-as-a-filler-binder-for-direct-compression/&t=FORMULATION%20AND%20EVALUATION%20OF%20A%202-%0ACOMPONENT%20COMPOSITE%20EXCIPIENT%0A%22MICROCRYSTARLAC%22%20AS%20A%20FILLER-BINDER%0AFOR%20DIRECT%20COMPRESSION" title="Tumblr" target="_blank" rel="noopener"></a></div></div></article> </body>